Date published: 2025-9-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Bax Activators

Bax activators are a class of molecules that play a pivotal role in regulating programmed cell death, a fundamental biological process known as apoptosis. These molecules are primarily involved in the intrinsic pathway of apoptosis, which is a tightly controlled mechanism used by multicellular organisms to eliminate damaged or unwanted cells. At the heart of this pathway lies the Bcl-2 protein family, which can be divided into two major groups: anti-apoptotic members, such as Bcl-2 itself, and pro-apoptotic members, including Bax. Bax activators are compounds that specifically interact with the pro-apoptotic protein Bax. Bax is normally present in an inactive form within the cytoplasm of cells, but when apoptosis is triggered, it undergoes a conformational change that enables it to translocate to the mitochondria, where it promotes the release of pro-apoptotic factors, ultimately leading to cell death. Bax activators facilitate this activation process, often by binding directly to Bax and inducing its activation. This can involve a series of structural changes in Bax that ultimately result in the formation of pores in the mitochondrial outer membrane, leading to the release of cytochrome c and other apoptotic factors.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Stat3 Inhibitor III, WP1066

857064-38-1sc-203282
10 mg
$132.00
72
(1)

Stat3 Inhibitor III, also known as WP1066, is notable for its ability to disrupt the Stat3 signaling pathway, which is crucial in various cellular processes. This compound selectively binds to the SH2 domain of Stat3, preventing its phosphorylation and subsequent dimerization. The inhibition alters downstream gene expression, impacting cellular proliferation and survival. Its unique interaction profile and kinetic behavior highlight its role in modulating transcriptional activity within the cell.

ABT 263

923564-51-6sc-207241
5 mg
$240.00
16
(1)

ABT-263 is a Bcl-2 family inhibitor that indirectly activates Bax by binding to and inhibiting anti-apoptotic proteins like Bcl-2 and Bcl-xL. This frees up pro-apoptotic proteins like Bim, allowing them to activate Bax.

ABT 737

852808-04-9sc-207242
2.5 mg
$200.00
54
(3)

Similar to ABT-263, ABT-737 is an inhibitor of Bcl-2 and Bcl-xL, promoting apoptosis by releasing pro-apoptotic proteins such as Bim and Bad to activate Bax.

TW-37

877877-35-5sc-361387
sc-361387A
10 mg
50 mg
$200.00
$860.00
2
(1)

TW-37 is a small molecule inhibitor that disrupts Bcl-2 and Bcl-xL interactions with pro-apoptotic proteins, leading to Bax activation.

HA14-1

65673-63-4sc-205911
sc-205911A
5 mg
25 mg
$58.00
$205.00
(1)

HA14-1 is known to target anti-apoptotic proteins like Bcl-2, releasing Bax and allowing it to initiate apoptosis.

Gossypol

303-45-7sc-200501
sc-200501A
25 mg
100 mg
$114.00
$225.00
12
(1)

Gossypol functions as a Bcl-2 family inhibitor, promoting apoptosis by disrupting the interactions between anti-apoptotic proteins and Bax.

Obatoclax

803712-67-6sc-507476
10 mg
$348.00
(0)

GX15-070 inhibits various Bcl-2 family members, including Bcl-2, Bcl-xL, and Mcl-1, thus indirectly activating Bax.

Sabutoclax

1228108-65-3sc-472977
1 mg
$330.00
(0)

Sabutoclax inhibits multiple anti-apoptotic Bcl-2 family members, leading to the activation of Bax and apoptosis.

A-1331852

1430844-80-6sc-507472
5 mg
$230.00
(0)

A-1331852 is a selective Bcl-xL inhibitor, disrupting the protective interaction between Bcl-xL and Bax, allowing Bax to promote apoptosis.

WEHI-539

1431866-33-9sc-507317
5 mg
$233.00
(0)

WEHI-539 is a potent Bcl-xL inhibitor, enabling Bax activation and apoptosis induction.